Advertisement

New Medications

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Research Summaries

Conference Coverage
pills
Conference Coverage
Study Finds Slightly Lower Risk of Richter Transformation for Patients With Chronic Lymphocytic Leukemia in the “Novel Agent Era”
03/13/2024

Anthony Calabro, MA

Anthony Calabro, MA
The study findings potentially challenge the conventional wisdom that the risk of Richter transformation would increase as patients with chronic lymphocytic leukemia live longer with novel treatments. This...
03/13/2024
FDA Alert
fda
FDA Alert
FDA Approves Irinotecan Liposome For First-Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma
03/04/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin as a first-line regimen for the management of patients with metastatic pancreatic adenocarcinoma.
03/04/2024
FDA Alert
FDA Alert
FDA Alert
FDA Approves Two Medications to Treat Pediatric Patients With Type 2 Diabetes
08/10/2023

Jessica Ganga

Jessica Ganga
The FDA has approved empagliflozin, and empagliflozin and hydrochloride to help manage type 2 diabetes in pediatric patients.
08/10/2023
FDA Alert
Child holding stomach
FDA Alert
First Treatment for Pediatric Functional Constipation Approved by FDA
06/15/2023

Jessica Ganga

Jessica Ganga
The FDA approved the first treatment for pediatric patients who experience functional constipation
06/15/2023
fda alert
fda
fda alert
FDA Approves Novel Treatment for Menopausal Hot Flashes
06/07/2023

Leigh Precopio

Leigh Precopio
The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.
06/07/2023
FDA ALERTS
FDA ALERTS
FDA Approves First Combination Inhaled Corticosteroid for Asthma
01/27/2023
Following a multicenter study, the FDA approved the combination of albuterol and budesonide—an inhaled corticosteroid—for the treatment of asthma in adults.
01/27/2023
Treatment
Treatment
FDA Accelerates Approval for New Alzheimer Treatment
01/10/2023
The FDA approved a treatment that targets one of the main causes of Alzheimer disease.
01/10/2023
Conference Coverage
Conference Coverage
New and Emerging Treatments in Managing Type 2 Diabetes, Obesity
11/18/2022
Emerging treatments have improved the standard of care for managing patients with both type 2 diabetes and obesity. Carol Wysham, MD, and Deborah B. Horn, DO, MPH, discuss these new treatments and...
11/18/2022
Treatment
Treatment
FDA Approves First Treatment to Delay Stage 3 Type 1 Diabetes
11/18/2022
The recent FDA approval of the first treatment in the delay of onset type 1 diabetes provides a crucial option for certain at-risk patients.
11/18/2022
Medication
Medication
A New Drug Combination Effective in Treating Urinary Tract Infections
10/26/2022
A new drug combination was found to be more effective for treating UTIs and acute pyelonephritis compared to the current standard treatment approach.
10/26/2022